In the research of Vella et al. (2001), they found that the activation of the insulin-like growth factor (IGF) system in cancer has emerged as a key factor for tumor progression and resistance to apoptosis, and experiments validated that IGF system members were found to be locally produced in thyroid cancer. The gene discussed is IGF1; the disease is thyroid gland carcinoma.